Plain-English translation of NCT05720663 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study is looking for better ways to monitor people who have advanced scarring (cirrhosis) in their livers caused by nonalcoholic fatty liver disease — a condition where fat builds up and damages the liver. Researchers want to see if three new tests — a special ultrasound that measures spleen stiffness, and two types of MRI scans — can help predict when the liver might start to fail, so doctors can step in sooner.
Right now, doctors use standard blood tests to monitor patients with advanced liver scarring, but these tests don't always catch early warning signs that the liver is about to fail. This study exists to find better tools to predict serious complications like bleeding, fluid buildup in the belly, or brain confusion — so doctors can treat problems before they become emergencies.
You likely qualify if…
You likely don't qualify if…
If you join this study, you will continue your regular blood tests and doctor visits, and you will also receive three additional imaging tests: a specialized ultrasound that measures how stiff your spleen is, and two types of MRI scans that look at your liver in detail. Researchers will use information from all these tests to see which ones best predict when your liver might start to fail, helping guide better care for people like you in the future.
AI-generated summary from trial data · Jun 9, 2026 · Not medical advice
United States